nodes	percent_of_prediction	percent_of_DWPC	metapath
Liothyronine—SLC10A1—Ethinyl Estradiol—prostate cancer	0.0759	0.102	CbGbCtD
Liothyronine—SLCO4A1—Conjugated Estrogens—prostate cancer	0.0701	0.0943	CbGbCtD
Liothyronine—SLCO4A1—Estradiol—prostate cancer	0.0616	0.0828	CbGbCtD
Liothyronine—SLC10A1—Conjugated Estrogens—prostate cancer	0.0557	0.0749	CbGbCtD
Liothyronine—SLCO1C1—Conjugated Estrogens—prostate cancer	0.0492	0.0662	CbGbCtD
Liothyronine—SLCO1C1—Estradiol—prostate cancer	0.0432	0.0581	CbGbCtD
Liothyronine—SLCO1B3—Cabazitaxel—prostate cancer	0.043	0.0578	CbGbCtD
Liothyronine—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0275	0.037	CbGbCtD
Liothyronine—SLCO1A2—Estrone—prostate cancer	0.026	0.0349	CbGbCtD
Liothyronine—SLCO1B1—Cabazitaxel—prostate cancer	0.0251	0.0337	CbGbCtD
Liothyronine—SLCO1B1—Estrone—prostate cancer	0.0245	0.0329	CbGbCtD
Liothyronine—SLCO1B3—Estradiol—prostate cancer	0.0241	0.0325	CbGbCtD
Liothyronine—ALB—Abiraterone—prostate cancer	0.0185	0.0249	CbGbCtD
Liothyronine—SLCO1A2—Conjugated Estrogens—prostate cancer	0.017	0.0228	CbGbCtD
Liothyronine—SLCO1B1—Conjugated Estrogens—prostate cancer	0.016	0.0215	CbGbCtD
Liothyronine—SLCO1A2—Estradiol—prostate cancer	0.0149	0.02	CbGbCtD
Liothyronine—SLC22A8—Conjugated Estrogens—prostate cancer	0.0148	0.0199	CbGbCtD
Liothyronine—SLCO1B3—Docetaxel—prostate cancer	0.0144	0.0194	CbGbCtD
Liothyronine—SLCO1B1—Estradiol—prostate cancer	0.0141	0.0189	CbGbCtD
Liothyronine—ALB—Estrone—prostate cancer	0.0134	0.018	CbGbCtD
Liothyronine—SLC22A8—Estradiol—prostate cancer	0.013	0.0175	CbGbCtD
Liothyronine—SLCO1A2—Prednisone—prostate cancer	0.0128	0.0172	CbGbCtD
Liothyronine—ABCB1—Estramustine—prostate cancer	0.0109	0.0146	CbGbCtD
Liothyronine—ALB—Estradiol—prostate cancer	0.0077	0.0104	CbGbCtD
Liothyronine—Cardio-respiratory arrest—Abiraterone—prostate cancer	0.00754	0.0972	CcSEcCtD
Liothyronine—ABCB1—Cabazitaxel—prostate cancer	0.00718	0.00965	CbGbCtD
Liothyronine—ABCB1—Estrone—prostate cancer	0.00701	0.00943	CbGbCtD
Liothyronine—ALB—Prednisone—prostate cancer	0.00662	0.0089	CbGbCtD
Liothyronine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00625	0.00841	CbGbCtD
Liothyronine—TTR—urine—prostate cancer	0.00487	0.0776	CbGeAlD
Liothyronine—ABCB1—Conjugated Estrogens—prostate cancer	0.00459	0.00617	CbGbCtD
Liothyronine—ABCB1—Mitoxantrone—prostate cancer	0.00417	0.00561	CbGbCtD
Liothyronine—ABCB1—Estradiol—prostate cancer	0.00403	0.00542	CbGbCtD
Liothyronine—ABCB1—Prednisone—prostate cancer	0.00346	0.00466	CbGbCtD
Liothyronine—SLC22A8—urine—prostate cancer	0.00299	0.0476	CbGeAlD
Liothyronine—ABCB1—Etoposide—prostate cancer	0.00263	0.00354	CbGbCtD
Liothyronine—ABCB1—Docetaxel—prostate cancer	0.00241	0.00324	CbGbCtD
Liothyronine—THRA—prostate gland—prostate cancer	0.00235	0.0375	CbGeAlD
Liothyronine—THRB—prostate gland—prostate cancer	0.00235	0.0375	CbGeAlD
Liothyronine—Cardiac failure congestive—Estramustine—prostate cancer	0.00222	0.0286	CcSEcCtD
Liothyronine—SLC10A1—prostate gland—prostate cancer	0.00208	0.0332	CbGeAlD
Liothyronine—SLCO4C1—seminal vesicle—prostate cancer	0.00208	0.0331	CbGeAlD
Liothyronine—SERPINA7—bone marrow—prostate cancer	0.00196	0.0313	CbGeAlD
Liothyronine—SLC7A5—prostate gland—prostate cancer	0.0018	0.0286	CbGeAlD
Liothyronine—ABCB1—Doxorubicin—prostate cancer	0.00179	0.00241	CbGbCtD
Liothyronine—SLC10A1—seminal vesicle—prostate cancer	0.00176	0.028	CbGeAlD
Liothyronine—SLCO4C1—renal system—prostate cancer	0.00167	0.0267	CbGeAlD
Liothyronine—THRA—renal system—prostate cancer	0.0016	0.0256	CbGeAlD
Liothyronine—THRB—renal system—prostate cancer	0.0016	0.0256	CbGeAlD
Liothyronine—SLCO4A1—prostate gland—prostate cancer	0.00157	0.025	CbGeAlD
Liothyronine—Acute coronary syndrome—Estramustine—prostate cancer	0.00153	0.0197	CcSEcCtD
Liothyronine—Myocardial infarction—Estramustine—prostate cancer	0.00152	0.0196	CcSEcCtD
Liothyronine—SLC7A5—seminal vesicle—prostate cancer	0.00152	0.0242	CbGeAlD
Liothyronine—Angina pectoris—Nilutamide—prostate cancer	0.0015	0.0194	CcSEcCtD
Liothyronine—Acute coronary syndrome—Abiraterone—prostate cancer	0.00148	0.0191	CcSEcCtD
Liothyronine—Myocardial infarction—Abiraterone—prostate cancer	0.00148	0.019	CcSEcCtD
Liothyronine—Acute coronary syndrome—Estrone—prostate cancer	0.00146	0.0188	CcSEcCtD
Liothyronine—Myocardial infarction—Estrone—prostate cancer	0.00145	0.0187	CcSEcCtD
Liothyronine—Cardiac failure congestive—Bicalutamide—prostate cancer	0.00142	0.0183	CcSEcCtD
Liothyronine—SLC10A1—renal system—prostate cancer	0.00142	0.0226	CbGeAlD
Liothyronine—SLC16A10—prostate gland—prostate cancer	0.00138	0.0219	CbGeAlD
Liothyronine—SLCO1C1—renal system—prostate cancer	0.00133	0.0212	CbGeAlD
Liothyronine—SLCO4A1—seminal vesicle—prostate cancer	0.00133	0.0211	CbGeAlD
Liothyronine—SLC7A5—epithelium—prostate cancer	0.00132	0.021	CbGeAlD
Liothyronine—Acute coronary syndrome—Estradiol valerate/Dienogest—prostate cancer	0.00127	0.0164	CcSEcCtD
Liothyronine—Myocardial infarction—Estradiol valerate/Dienogest—prostate cancer	0.00127	0.0163	CcSEcCtD
Liothyronine—SLCO4C1—bone marrow—prostate cancer	0.00127	0.0202	CbGeAlD
Liothyronine—Acute coronary syndrome—Degarelix—prostate cancer	0.00121	0.0156	CcSEcCtD
Liothyronine—Arrhythmia—Abiraterone—prostate cancer	0.00121	0.0156	CcSEcCtD
Liothyronine—Myocardial infarction—Degarelix—prostate cancer	0.0012	0.0155	CcSEcCtD
Liothyronine—SLC7A5—urethra—prostate cancer	0.0012	0.0192	CbGeAlD
Liothyronine—TTR—renal system—prostate cancer	0.00119	0.019	CbGeAlD
Liothyronine—L-Tyrosine—TH—prostate cancer	0.00114	0.562	CrCbGaD
Liothyronine—Angina pectoris—Bicalutamide—prostate cancer	0.00108	0.014	CcSEcCtD
Liothyronine—SLC22A8—prostate gland—prostate cancer	0.00107	0.0171	CbGeAlD
Liothyronine—SLCO4A1—renal system—prostate cancer	0.00107	0.017	CbGeAlD
Liothyronine—SLCO4A1—urethra—prostate cancer	0.00105	0.0167	CbGeAlD
Liothyronine—THRA—testis—prostate cancer	0.00104	0.0165	CbGeAlD
Liothyronine—THRB—testis—prostate cancer	0.00104	0.0165	CbGeAlD
Liothyronine—Phlebitis—Conjugated Estrogens—prostate cancer	0.00103	0.0133	CcSEcCtD
Liothyronine—Hypertension—Abiraterone—prostate cancer	0.00102	0.0131	CcSEcCtD
Liothyronine—SLC16A10—epithelium—prostate cancer	0.00101	0.0161	CbGeAlD
Liothyronine—Cardiac failure congestive—Goserelin—prostate cancer	0.000988	0.0127	CcSEcCtD
Liothyronine—Arrhythmia—Degarelix—prostate cancer	0.000985	0.0127	CcSEcCtD
Liothyronine—Cardiac failure congestive—Conjugated Estrogens—prostate cancer	0.000979	0.0126	CcSEcCtD
Liothyronine—Acute coronary syndrome—Bicalutamide—prostate cancer	0.000979	0.0126	CcSEcCtD
Liothyronine—Myocardial infarction—Bicalutamide—prostate cancer	0.000973	0.0125	CcSEcCtD
Liothyronine—SLCO1B1—renal system—prostate cancer	0.000941	0.015	CbGeAlD
Liothyronine—Arrhythmia—Cabazitaxel—prostate cancer	0.000928	0.012	CcSEcCtD
Liothyronine—Hypertension—Nilutamide—prostate cancer	0.000928	0.012	CcSEcCtD
Liothyronine—SLC7A5—bone marrow—prostate cancer	0.000926	0.0147	CbGeAlD
Liothyronine—Hypertension—Flutamide—prostate cancer	0.000924	0.0119	CcSEcCtD
Liothyronine—SLC10A1—testis—prostate cancer	0.000917	0.0146	CbGeAlD
Liothyronine—TTR—bone marrow—prostate cancer	0.000902	0.0144	CbGeAlD
Liothyronine—SLCO1C1—testis—prostate cancer	0.000862	0.0137	CbGeAlD
Liothyronine—Hypertension—Degarelix—prostate cancer	0.000829	0.0107	CcSEcCtD
Liothyronine—Acute coronary syndrome—Ethinyl Estradiol—prostate cancer	0.000827	0.0107	CcSEcCtD
Liothyronine—Phlebitis—Estradiol—prostate cancer	0.000825	0.0106	CcSEcCtD
Liothyronine—Myocardial infarction—Ethinyl Estradiol—prostate cancer	0.000823	0.0106	CcSEcCtD
Liothyronine—Arrhythmia—Bicalutamide—prostate cancer	0.000796	0.0103	CcSEcCtD
Liothyronine—SLC7A5—testis—prostate cancer	0.000791	0.0126	CbGeAlD
Liothyronine—Hypertension—Cabazitaxel—prostate cancer	0.000781	0.0101	CcSEcCtD
Liothyronine—TTR—testis—prostate cancer	0.000771	0.0123	CbGeAlD
Liothyronine—Phlebitis—Mitoxantrone—prostate cancer	0.000769	0.00991	CcSEcCtD
Liothyronine—SLCO1A2—renal system—prostate cancer	0.000766	0.0122	CbGeAlD
Liothyronine—Body temperature increased—Abiraterone—prostate cancer	0.000759	0.00979	CcSEcCtD
Liothyronine—Angina pectoris—Goserelin—prostate cancer	0.000755	0.00973	CcSEcCtD
Liothyronine—THRB—lymph node—prostate cancer	0.000752	0.012	CbGeAlD
Liothyronine—THRA—lymph node—prostate cancer	0.000752	0.012	CbGeAlD
Liothyronine—Hypotension—Degarelix—prostate cancer	0.000732	0.00944	CcSEcCtD
Liothyronine—SLC22A8—renal system—prostate cancer	0.000731	0.0116	CbGeAlD
Liothyronine—Cardiac failure congestive—Mitoxantrone—prostate cancer	0.00073	0.00941	CcSEcCtD
Liothyronine—Tachycardia—Cabazitaxel—prostate cancer	0.000721	0.00929	CcSEcCtD
Liothyronine—Body temperature increased—Nilutamide—prostate cancer	0.000694	0.00894	CcSEcCtD
Liothyronine—SLCO4A1—testis—prostate cancer	0.000691	0.011	CbGeAlD
Liothyronine—Hypotension—Cabazitaxel—prostate cancer	0.00069	0.00889	CcSEcCtD
Liothyronine—Acute coronary syndrome—Goserelin—prostate cancer	0.000681	0.00878	CcSEcCtD
Liothyronine—Myocardial infarction—Goserelin—prostate cancer	0.000677	0.00873	CcSEcCtD
Liothyronine—Acute coronary syndrome—Conjugated Estrogens—prostate cancer	0.000675	0.0087	CcSEcCtD
Liothyronine—Myocardial infarction—Conjugated Estrogens—prostate cancer	0.000671	0.00865	CcSEcCtD
Liothyronine—Hypertension—Bicalutamide—prostate cancer	0.00067	0.00864	CcSEcCtD
Liothyronine—L-Phenylalanine—TH—prostate cancer	0.000662	0.326	CrCbGaD
Liothyronine—Phlebitis—Etoposide—prostate cancer	0.000639	0.00824	CcSEcCtD
Liothyronine—SLCO1C1—lymph node—prostate cancer	0.000625	0.00996	CbGeAlD
Liothyronine—Body temperature increased—Degarelix—prostate cancer	0.00062	0.00799	CcSEcCtD
Liothyronine—Cardiac failure congestive—Etoposide—prostate cancer	0.000607	0.00783	CcSEcCtD
Liothyronine—SLC16A10—testis—prostate cancer	0.000606	0.00965	CbGeAlD
Liothyronine—Body temperature increased—Cabazitaxel—prostate cancer	0.000584	0.00752	CcSEcCtD
Liothyronine—SLC7A5—lymph node—prostate cancer	0.000574	0.00914	CbGeAlD
Liothyronine—SLC7A5—Desoximetasone—Prednisone—prostate cancer	0.000572	1	CbGdCrCtD
Liothyronine—Arrhythmia—Goserelin—prostate cancer	0.000554	0.00714	CcSEcCtD
Liothyronine—Arrhythmia—Conjugated Estrogens—prostate cancer	0.000549	0.00707	CcSEcCtD
Liothyronine—Acute coronary syndrome—Estradiol—prostate cancer	0.00054	0.00696	CcSEcCtD
Liothyronine—Myocardial infarction—Estradiol—prostate cancer	0.000537	0.00692	CcSEcCtD
Liothyronine—Phlebitis—Docetaxel—prostate cancer	0.000531	0.00685	CcSEcCtD
Liothyronine—Phlebitis—Capecitabine—prostate cancer	0.000514	0.00663	CcSEcCtD
Liothyronine—Cardiac failure congestive—Docetaxel—prostate cancer	0.000505	0.00651	CcSEcCtD
Liothyronine—Acute coronary syndrome—Mitoxantrone—prostate cancer	0.000503	0.00648	CcSEcCtD
Liothyronine—SLCO4A1—lymph node—prostate cancer	0.000501	0.00798	CbGeAlD
Liothyronine—Body temperature increased—Bicalutamide—prostate cancer	0.000501	0.00645	CcSEcCtD
Liothyronine—Myocardial infarction—Mitoxantrone—prostate cancer	0.0005	0.00645	CcSEcCtD
Liothyronine—SLCO1A2—testis—prostate cancer	0.000495	0.00788	CbGeAlD
Liothyronine—ALB—testis—prostate cancer	0.000492	0.00784	CbGeAlD
Liothyronine—Hypertension—Goserelin—prostate cancer	0.000466	0.00601	CcSEcCtD
Liothyronine—SLC16A10—lymph node—prostate cancer	0.000439	0.007	CbGeAlD
Liothyronine—Cardiac failure congestive—Prednisone—prostate cancer	0.000435	0.00561	CcSEcCtD
Liothyronine—Tachycardia—Goserelin—prostate cancer	0.00043	0.00554	CcSEcCtD
Liothyronine—Tachycardia—Conjugated Estrogens—prostate cancer	0.000426	0.00549	CcSEcCtD
Liothyronine—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000423	0.00546	CcSEcCtD
Liothyronine—Acute coronary syndrome—Etoposide—prostate cancer	0.000418	0.00539	CcSEcCtD
Liothyronine—Myocardial infarction—Etoposide—prostate cancer	0.000416	0.00536	CcSEcCtD
Liothyronine—Hypotension—Goserelin—prostate cancer	0.000412	0.00531	CcSEcCtD
Liothyronine—Arrhythmia—Mitoxantrone—prostate cancer	0.000409	0.00528	CcSEcCtD
Liothyronine—Hypotension—Conjugated Estrogens—prostate cancer	0.000408	0.00526	CcSEcCtD
Liothyronine—Angina pectoris—Docetaxel—prostate cancer	0.000385	0.00497	CcSEcCtD
Liothyronine—ABCB1—prostate gland—prostate cancer	0.000376	0.00599	CbGeAlD
Liothyronine—Angina pectoris—Capecitabine—prostate cancer	0.000373	0.00481	CcSEcCtD
Liothyronine—Hypertension—Estradiol—prostate cancer	0.000369	0.00476	CcSEcCtD
Liothyronine—Phlebitis—Epirubicin—prostate cancer	0.000358	0.00462	CcSEcCtD
Liothyronine—ALB—lymph node—prostate cancer	0.000357	0.00568	CbGeAlD
Liothyronine—Body temperature increased—Goserelin—prostate cancer	0.000348	0.00449	CcSEcCtD
Liothyronine—Acute coronary syndrome—Docetaxel—prostate cancer	0.000348	0.00448	CcSEcCtD
Liothyronine—Myocardial infarction—Docetaxel—prostate cancer	0.000346	0.00446	CcSEcCtD
Liothyronine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000345	0.00445	CcSEcCtD
Liothyronine—Hypertension—Mitoxantrone—prostate cancer	0.000344	0.00444	CcSEcCtD
Liothyronine—Tachycardia—Estradiol—prostate cancer	0.000341	0.00439	CcSEcCtD
Liothyronine—Cardiac failure congestive—Epirubicin—prostate cancer	0.00034	0.00439	CcSEcCtD
Liothyronine—Acute coronary syndrome—Capecitabine—prostate cancer	0.000337	0.00434	CcSEcCtD
Liothyronine—Myocardial infarction—Capecitabine—prostate cancer	0.000335	0.00432	CcSEcCtD
Liothyronine—Phlebitis—Doxorubicin—prostate cancer	0.000332	0.00427	CcSEcCtD
Liothyronine—ABCB1—seminal vesicle—prostate cancer	0.000318	0.00507	CbGeAlD
Liothyronine—Tachycardia—Mitoxantrone—prostate cancer	0.000318	0.00409	CcSEcCtD
Liothyronine—Cardiac failure congestive—Doxorubicin—prostate cancer	0.000315	0.00406	CcSEcCtD
Liothyronine—Hypotension—Mitoxantrone—prostate cancer	0.000304	0.00392	CcSEcCtD
Liothyronine—Acute coronary syndrome—Prednisone—prostate cancer	0.0003	0.00387	CcSEcCtD
Liothyronine—Myocardial infarction—Prednisone—prostate cancer	0.000298	0.00384	CcSEcCtD
Liothyronine—Hypertension—Etoposide—prostate cancer	0.000286	0.00369	CcSEcCtD
Liothyronine—Arrhythmia—Docetaxel—prostate cancer	0.000283	0.00365	CcSEcCtD
Liothyronine—ABCB1—epithelium—prostate cancer	0.000276	0.0044	CbGeAlD
Liothyronine—Body temperature increased—Estradiol—prostate cancer	0.000276	0.00356	CcSEcCtD
Liothyronine—Arrhythmia—Capecitabine—prostate cancer	0.000274	0.00353	CcSEcCtD
Liothyronine—Tachycardia—Etoposide—prostate cancer	0.000264	0.00341	CcSEcCtD
Liothyronine—Angina pectoris—Epirubicin—prostate cancer	0.00026	0.00335	CcSEcCtD
Liothyronine—Body temperature increased—Mitoxantrone—prostate cancer	0.000257	0.00332	CcSEcCtD
Liothyronine—ABCB1—renal system—prostate cancer	0.000256	0.00408	CbGeAlD
Liothyronine—Hypotension—Etoposide—prostate cancer	0.000253	0.00326	CcSEcCtD
Liothyronine—ABCB1—urethra—prostate cancer	0.000252	0.00401	CbGeAlD
Liothyronine—Arrhythmia—Prednisone—prostate cancer	0.000244	0.00314	CcSEcCtD
Liothyronine—Angina pectoris—Doxorubicin—prostate cancer	0.00024	0.0031	CcSEcCtD
Liothyronine—Hypertension—Docetaxel—prostate cancer	0.000238	0.00307	CcSEcCtD
Liothyronine—Hypertension—Capecitabine—prostate cancer	0.00023	0.00297	CcSEcCtD
Liothyronine—Levothyroxine—CYP3A4—prostate cancer	0.000227	0.112	CrCbGaD
Liothyronine—Tachycardia—Docetaxel—prostate cancer	0.00022	0.00283	CcSEcCtD
Liothyronine—Body temperature increased—Etoposide—prostate cancer	0.000214	0.00276	CcSEcCtD
Liothyronine—Tachycardia—Capecitabine—prostate cancer	0.000213	0.00274	CcSEcCtD
Liothyronine—Hypotension—Docetaxel—prostate cancer	0.00021	0.00271	CcSEcCtD
Liothyronine—Hypertension—Prednisone—prostate cancer	0.000205	0.00265	CcSEcCtD
Liothyronine—Hypotension—Capecitabine—prostate cancer	0.000204	0.00262	CcSEcCtD
Liothyronine—ABCB1—bone marrow—prostate cancer	0.000194	0.00309	CbGeAlD
Liothyronine—Arrhythmia—Epirubicin—prostate cancer	0.000191	0.00246	CcSEcCtD
Liothyronine—Tachycardia—Prednisone—prostate cancer	0.000189	0.00244	CcSEcCtD
Liothyronine—Body temperature increased—Docetaxel—prostate cancer	0.000178	0.00229	CcSEcCtD
Liothyronine—Arrhythmia—Doxorubicin—prostate cancer	0.000177	0.00228	CcSEcCtD
Liothyronine—Body temperature increased—Capecitabine—prostate cancer	0.000172	0.00222	CcSEcCtD
Liothyronine—ABCB1—testis—prostate cancer	0.000166	0.00264	CbGeAlD
Liothyronine—Hypertension—Epirubicin—prostate cancer	0.000161	0.00207	CcSEcCtD
Liothyronine—Body temperature increased—Prednisone—prostate cancer	0.000153	0.00198	CcSEcCtD
Liothyronine—Hypertension—Doxorubicin—prostate cancer	0.000149	0.00191	CcSEcCtD
Liothyronine—Tachycardia—Epirubicin—prostate cancer	0.000148	0.00191	CcSEcCtD
Liothyronine—Hypotension—Epirubicin—prostate cancer	0.000142	0.00183	CcSEcCtD
Liothyronine—Tachycardia—Doxorubicin—prostate cancer	0.000137	0.00177	CcSEcCtD
Liothyronine—Hypotension—Doxorubicin—prostate cancer	0.000131	0.00169	CcSEcCtD
Liothyronine—ABCB1—lymph node—prostate cancer	0.00012	0.00191	CbGeAlD
Liothyronine—Body temperature increased—Epirubicin—prostate cancer	0.00012	0.00155	CcSEcCtD
Liothyronine—Body temperature increased—Doxorubicin—prostate cancer	0.000111	0.00143	CcSEcCtD
Liothyronine—TTR—Signaling Pathways—MDM2—prostate cancer	5.76e-06	5.08e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—MYC—prostate cancer	5.74e-06	5.07e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTA1—prostate cancer	5.73e-06	5.05e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—TGFB1—prostate cancer	5.73e-06	5.05e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTM1—prostate cancer	5.73e-06	5.05e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PTEN—prostate cancer	5.72e-06	5.05e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.68e-06	5.01e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—ERBB2—prostate cancer	5.68e-06	5.01e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NAT2—prostate cancer	5.67e-06	5e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HSD3B2—prostate cancer	5.67e-06	5e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTO1—prostate cancer	5.67e-06	5e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—CAV1—prostate cancer	5.63e-06	4.96e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—LPL—prostate cancer	5.62e-06	4.96e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—EGFR—prostate cancer	5.62e-06	4.95e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3CB—prostate cancer	5.6e-06	4.94e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HSD3B1—prostate cancer	5.57e-06	4.91e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC22A3—prostate cancer	5.57e-06	4.91e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—RXRA—prostate cancer	5.56e-06	4.9e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—EP300—prostate cancer	5.46e-06	4.81e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	5.46e-06	4.81e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.45e-06	4.81e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—LRP2—prostate cancer	5.43e-06	4.79e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PLCB2—prostate cancer	5.43e-06	4.79e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP2C18—prostate cancer	5.43e-06	4.79e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CYP1A1—prostate cancer	5.43e-06	4.79e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CG—prostate cancer	5.41e-06	4.77e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.41e-06	4.77e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	5.39e-06	4.75e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ERCC2—prostate cancer	5.39e-06	4.75e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CXCL8—prostate cancer	5.38e-06	4.75e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	5.37e-06	4.74e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—COMT—prostate cancer	5.36e-06	4.72e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTA4—prostate cancer	5.34e-06	4.71e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—TBXAS1—prostate cancer	5.34e-06	4.71e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTP1—prostate cancer	5.33e-06	4.7e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—P4HB—prostate cancer	5.33e-06	4.7e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—KRAS—prostate cancer	5.31e-06	4.68e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	5.27e-06	4.65e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CDKN1B—prostate cancer	5.26e-06	4.64e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ITPR1—prostate cancer	5.25e-06	4.63e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTA2—prostate cancer	5.2e-06	4.59e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SLC22A1—prostate cancer	5.18e-06	4.57e-05	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	5.18e-06	4.57e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.16e-06	4.55e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CASP3—prostate cancer	5.15e-06	4.54e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL2—prostate cancer	5.14e-06	4.54e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ABCG5—prostate cancer	5.14e-06	4.53e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SULT1A1—prostate cancer	5.14e-06	4.53e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CG—prostate cancer	5.13e-06	4.52e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—INS—prostate cancer	5.12e-06	4.52e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.12e-06	4.52e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—EGF—prostate cancer	5.07e-06	4.47e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—MTHFR—prostate cancer	5.06e-06	4.46e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SULT2A1—prostate cancer	5.05e-06	4.45e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTA1—prostate cancer	5.02e-06	4.43e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—CREBBP—prostate cancer	5.02e-06	4.43e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CCND1—prostate cancer	5.02e-06	4.42e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	4.98e-06	4.39e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MED12—prostate cancer	4.97e-06	4.38e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PPARA—prostate cancer	4.97e-06	4.38e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CTNNB1—prostate cancer	4.97e-06	4.38e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTO1—prostate cancer	4.97e-06	4.38e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NAT2—prostate cancer	4.97e-06	4.38e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HSD3B2—prostate cancer	4.97e-06	4.38e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—TYMS—prostate cancer	4.96e-06	4.37e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GNG5—prostate cancer	4.93e-06	4.35e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTM1—prostate cancer	4.9e-06	4.32e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—PIK3CA—prostate cancer	4.88e-06	4.3e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MMP9—prostate cancer	4.87e-06	4.29e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CDKN1A—prostate cancer	4.85e-06	4.28e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PTEN—prostate cancer	4.84e-06	4.27e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—LPL—prostate cancer	4.81e-06	4.24e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP2C18—prostate cancer	4.76e-06	4.2e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—LRP2—prostate cancer	4.76e-06	4.2e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PLCB2—prostate cancer	4.76e-06	4.2e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CD—prostate cancer	4.76e-06	4.2e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—CREBBP—prostate cancer	4.75e-06	4.19e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOA3—prostate cancer	4.75e-06	4.19e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IGF1—prostate cancer	4.69e-06	4.14e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CAV1—prostate cancer	4.67e-06	4.12e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—P4HB—prostate cancer	4.67e-06	4.12e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.67e-06	4.12e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	4.65e-06	4.1e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CYP1A1—prostate cancer	4.64e-06	4.1e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EP300—prostate cancer	4.62e-06	4.07e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ERCC2—prostate cancer	4.61e-06	4.06e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	4.57e-06	4.03e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC22A1—prostate cancer	4.54e-06	4e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.54e-06	4e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HPGDS—prostate cancer	4.53e-06	4e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CD—prostate cancer	4.51e-06	3.97e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP2C19—prostate cancer	4.5e-06	3.97e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—NOS3—prostate cancer	4.49e-06	3.96e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—SRC—prostate cancer	4.49e-06	3.96e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.46e-06	3.93e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SERPINE1—prostate cancer	4.46e-06	3.93e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SULT2A1—prostate cancer	4.43e-06	3.9e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.42e-06	3.9e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ACHE—prostate cancer	4.39e-06	3.87e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTT1—prostate cancer	4.39e-06	3.87e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—VEGFA—prostate cancer	4.37e-06	3.86e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MED12—prostate cancer	4.35e-06	3.84e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP2A6—prostate cancer	4.34e-06	3.83e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—MTHFR—prostate cancer	4.33e-06	3.82e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—STAT3—prostate cancer	4.33e-06	3.82e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.33e-06	3.82e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GNG5—prostate cancer	4.32e-06	3.81e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—IL6—prostate cancer	4.32e-06	3.81e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—NOS3—prostate cancer	4.26e-06	3.75e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CG—prostate cancer	4.25e-06	3.75e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PPARA—prostate cancer	4.25e-06	3.75e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—AKR1C3—prostate cancer	4.23e-06	3.73e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PRKACB—prostate cancer	4.2e-06	3.71e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOA3—prostate cancer	4.16e-06	3.67e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP17A1—prostate cancer	4.16e-06	3.67e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CB—prostate cancer	4.15e-06	3.66e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—JAK2—prostate cancer	4.14e-06	3.65e-05	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.11e-06	3.63e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTGS2—prostate cancer	4.11e-06	3.62e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.1e-06	3.62e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PIK3CA—prostate cancer	4.04e-06	3.56e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—INS—prostate cancer	4.03e-06	3.55e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MYC—prostate cancer	4.02e-06	3.55e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TGFB1—prostate cancer	4.01e-06	3.54e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CAV1—prostate cancer	3.99e-06	3.52e-05	CbGpPWpGaD
Liothyronine—TTR—Disease—AKT1—prostate cancer	3.98e-06	3.51e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HPGDS—prostate cancer	3.97e-06	3.5e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOA2—prostate cancer	3.96e-06	3.5e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP2C19—prostate cancer	3.94e-06	3.48e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CREBBP—prostate cancer	3.94e-06	3.48e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EGFR—prostate cancer	3.93e-06	3.47e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CB—prostate cancer	3.93e-06	3.46e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTT1—prostate cancer	3.85e-06	3.4e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ACHE—prostate cancer	3.85e-06	3.4e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.82e-06	3.36e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP2A6—prostate cancer	3.81e-06	3.36e-05	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	3.79e-06	3.35e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SLC5A5—prostate cancer	3.78e-06	3.33e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CD—prostate cancer	3.74e-06	3.3e-05	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.74e-06	3.29e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—KRAS—prostate cancer	3.72e-06	3.28e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—AKR1C3—prostate cancer	3.7e-06	3.26e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP2E1—prostate cancer	3.69e-06	3.26e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PRKACB—prostate cancer	3.68e-06	3.25e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NQO1—prostate cancer	3.65e-06	3.22e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP17A1—prostate cancer	3.64e-06	3.21e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CG—prostate cancer	3.64e-06	3.21e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IL2—prostate cancer	3.61e-06	3.18e-05	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.6e-06	3.18e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—TH—prostate cancer	3.6e-06	3.17e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTEN—prostate cancer	3.58e-06	3.16e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.58e-06	3.15e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP3A4—prostate cancer	3.56e-06	3.14e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.54e-06	3.12e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NOS3—prostate cancer	3.53e-06	3.11e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP1B1—prostate cancer	3.5e-06	3.09e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOA2—prostate cancer	3.47e-06	3.06e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—INS—prostate cancer	3.44e-06	3.04e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—EP300—prostate cancer	3.42e-06	3.01e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PIK3CA—prostate cancer	3.41e-06	3.01e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GGT1—prostate cancer	3.39e-06	2.99e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CREBBP—prostate cancer	3.37e-06	2.97e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOA1—prostate cancer	3.34e-06	2.95e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC5A5—prostate cancer	3.31e-06	2.92e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TP53—prostate cancer	3.3e-06	2.91e-05	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—AKT1—prostate cancer	3.3e-06	2.91e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP19A1—prostate cancer	3.29e-06	2.9e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CB—prostate cancer	3.26e-06	2.87e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—EP300—prostate cancer	3.24e-06	2.85e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP2E1—prostate cancer	3.24e-06	2.85e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTGS2—prostate cancer	3.23e-06	2.85e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NQO1—prostate cancer	3.2e-06	2.82e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CD—prostate cancer	3.2e-06	2.82e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—RXRA—prostate cancer	3.18e-06	2.8e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—TH—prostate cancer	3.15e-06	2.78e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SRC—prostate cancer	3.15e-06	2.78e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP3A4—prostate cancer	3.12e-06	2.75e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.09e-06	2.72e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP1B1—prostate cancer	3.07e-06	2.71e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—VEGFA—prostate cancer	3.07e-06	2.7e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—COMT—prostate cancer	3.06e-06	2.7e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTP1—prostate cancer	3.05e-06	2.69e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL6—prostate cancer	3.02e-06	2.67e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NOS3—prostate cancer	3.02e-06	2.66e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ITPR1—prostate cancer	3e-06	2.64e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GGT1—prostate cancer	2.97e-06	2.62e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.95e-06	2.6e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOA1—prostate cancer	2.93e-06	2.58e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP19A1—prostate cancer	2.88e-06	2.54e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—TYMS—prostate cancer	2.83e-06	2.5e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTEN—prostate cancer	2.82e-06	2.48e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TGFB1—prostate cancer	2.81e-06	2.48e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTM1—prostate cancer	2.8e-06	2.47e-05	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—AKT1—prostate cancer	2.79e-06	2.46e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CB—prostate cancer	2.79e-06	2.46e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—RXRA—prostate cancer	2.78e-06	2.45e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTGS2—prostate cancer	2.76e-06	2.44e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—LPL—prostate cancer	2.75e-06	2.42e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—EP300—prostate cancer	2.69e-06	2.37e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—COMT—prostate cancer	2.68e-06	2.36e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTP1—prostate cancer	2.67e-06	2.35e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP1A1—prostate cancer	2.65e-06	2.34e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ERCC2—prostate cancer	2.63e-06	2.32e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ITPR1—prostate cancer	2.63e-06	2.32e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—KRAS—prostate cancer	2.61e-06	2.3e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PIK3CA—prostate cancer	2.53e-06	2.23e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—TYMS—prostate cancer	2.48e-06	2.19e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MTHFR—prostate cancer	2.47e-06	2.18e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTM1—prostate cancer	2.45e-06	2.16e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PPARA—prostate cancer	2.43e-06	2.14e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTEN—prostate cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—LPL—prostate cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PIK3CA—prostate cancer	2.39e-06	2.11e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP1A1—prostate cancer	2.32e-06	2.05e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TP53—prostate cancer	2.32e-06	2.04e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ERCC2—prostate cancer	2.31e-06	2.03e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—EP300—prostate cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CAV1—prostate cancer	2.28e-06	2.01e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.18e-06	1.92e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MTHFR—prostate cancer	2.17e-06	1.91e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PPARA—prostate cancer	2.13e-06	1.88e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CG—prostate cancer	2.08e-06	1.83e-05	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—AKT1—prostate cancer	2.07e-06	1.82e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CAV1—prostate cancer	2e-06	1.76e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.99e-06	1.75e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—INS—prostate cancer	1.97e-06	1.73e-05	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—AKT1—prostate cancer	1.96e-06	1.72e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CREBBP—prostate cancer	1.93e-06	1.7e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CD—prostate cancer	1.83e-06	1.61e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.82e-06	1.61e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NOS3—prostate cancer	1.73e-06	1.52e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—INS—prostate cancer	1.72e-06	1.52e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CREBBP—prostate cancer	1.69e-06	1.49e-05	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—AKT1—prostate cancer	1.62e-06	1.43e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.6e-06	1.41e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CB—prostate cancer	1.59e-06	1.4e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTGS2—prostate cancer	1.58e-06	1.39e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NOS3—prostate cancer	1.51e-06	1.33e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.4e-06	1.23e-05	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—AKT1—prostate cancer	1.39e-06	1.22e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTGS2—prostate cancer	1.38e-06	1.22e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTEN—prostate cancer	1.38e-06	1.21e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—EP300—prostate cancer	1.31e-06	1.16e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTEN—prostate cancer	1.21e-06	1.06e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—EP300—prostate cancer	1.15e-06	1.01e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PIK3CA—prostate cancer	9.71e-07	8.56e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PIK3CA—prostate cancer	8.51e-07	7.5e-06	CbGpPWpGaD
Liothyronine—ALB—Metabolism—AKT1—prostate cancer	7.93e-07	6.99e-06	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—AKT1—prostate cancer	6.95e-07	6.13e-06	CbGpPWpGaD
